Non-therapeutic anti-FXa levels are common among medical ward patients treated with enoxaparin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Non-therapeutic anti-FXa levels are common among medical ward patients treated with enoxaparin

Published:2011-03-16 Issue:11 Volume:90 Page:1345-1351
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Saliba Walid,Nitzan Orna,Rock Wasseem,Ron Gilat,Zalman Luci,Goldstein Lee,Lavi Idit,Elias Mazen

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-011-1208-1.pdf

Reference25 articles.

1. Greinacher A, Alban S, Omer-Adam MA, Weitschies W, Warkentin TE (2008) Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings. Thromb Res 122:211–220

2. Berges A, Laporte S, Epinat M, Zufferey P, Alamartine E, Tranchand B, Decousus H, Mismetti P, PROPHRE.75 Study Group (2007) Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years old. Br J Clin Pharmacol 64:428–438

3. Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ, American College of Chest Physician (2008) Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133(6 Suppl):110S–112S

4. The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators (1997) Dose-ranging trial of enoxaparin for unstable angina: results of TIMI 11A. J Am Coll Cardiol 29:1474–1482

5. Boneu B, de Moerloose P (2001) How and when to monitor a patient treated with low molecular weight heparin. Semin Thromb Hemost 27:519–522

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How enoxaparin underdosing and sex contribute to achieving therapeutic anti-Xa levels;Frontiers in Pharmacology;2024-07-12

2. Circulating heparan sulfate chains and body weight contribute to anti-Xa levels in cancer patients using the prophylactic dose of enoxaparin;Journal of Thrombosis and Thrombolysis;2020-05-06

3. Monitoring anti-Xa levels in patients with cancer-associated venous thromboembolism treated with bemiparin;Clinical and Translational Oncology;2019-12-20

4. Evaluation of therapeutic enoxaparin in a pregnant population at a tertiary hospital;Internal Medicine Journal;2016-07

5. Compliance With Enoxaparin Dosing and Monitoring Guidelines and the Impact on Patient Length of Stay;Therapeutic Drug Monitoring;2016-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3